Canopy Growth Corp (CGC) Financial Statements
Industry: Medicinal Chemicals & Botanical Products
In fiscal 2026, Canopy Growth reported revenue of $346.8M, up 10.5% from $314.0M the year before. Net income was -$262.9M (a -75.8% net margin), or -$0.88 per diluted share. Gross margin was 20.1% and operating margin was -46.6%. Operating activities generated -$63.8M of cash, leaving -$69.1M of free cash flow. At fiscal year end, Canopy Growth held $1.12B in total assets against $421.1M in total liabilities, including $364.7M of cash and equivalents.
Open the full interactive Canopy Growth financials → Quarterly statements, key ratios, valuation history and price charts.
Canopy Growth Key Stats
| Share Price | $0.76 |
|---|---|
| Market Cap | $322.2M |
| Revenue YoY Growth | +10.5% |
| 52-Week Range | $0.76 – $1.92 |
| Shares Outstanding | 422.3 million (basic, 2027 Q1) |
Canopy Growth Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $607.2M | $582.2M | $450.9M | $343.9M | $314.0M | $346.8M |
| Cost of Goods Sold | $479.7M | $713.4M | $507.0M | $216.3M | $189.5M | $214.9M |
| Gross Profit | $67.0M | -$193.1M | -$104.1M | $80.9M | $79.5M | $69.7M |
| Operating Income | -$1.24B | -$1.08B | -$2.85B | -$228.7M | -$117.1M | -$161.7M |
| Pre-Tax Income | -$1.68B | -$329.4M | -$3.31B | -$471.4M | -$597.0M | -$262.9M |
| Income Tax | -$13.1M | -$8.9M | -$4.8M | $12.3M | $7.1M | $23,000 |
| Net Income | -$1.74B | -$302.2M | -$3.28B | -$657.3M | -$598.1M | -$262.9M |
| Diluted EPS | -$46.90 | -$7.70 | -$70.70 | -$8.79 | -$5.56 | -$0.88 |
Canopy Growth Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $83.0M | $90.4M | $84.7M | $100.4M |
| Net Income | -$1.6M | -$62.6M | -$157.1M | -$14.6M |
| Diluted EPS | -$0.01 | -$0.18 | -$0.53 | -$0.03 |
Canopy Growth Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.15B | $776.0M | $677.0M | $170.3M | $113.8M | $364.7M |
| Current Assets | $2.84B | $1.74B | $1.08B | $371.2M | $294.6M | $529.5M |
| Total Assets | $6.82B | $5.62B | $2.44B | $1.30B | $917.7M | $1.12B |
| Current Liabilities | $284.3M | $212.9M | $803.8M | $234.7M | $94.4M | $158.4M |
| Total Long-Term Debt | $1.58B | $1.50B | $1.31B | $597.2M | $304.1M | $233.4M |
| Total Liabilities | $3.20B | $1.98B | $1.68B | $799.8M | $430.5M | $421.1M |
| Shareholders' Equity | $3.48B | $3.59B | $758.4M | $500.4M | $487.2M | $697.6M |
Canopy Growth Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$465.7M | -$545.8M | -$557.5M | -$281.9M | -$165.8M | -$63.8M |
| Cash From Investing | -$884.1M | $230.8M | $433.4M | $241.6M | -$47.8M | -$21.3M |
| Cash From Financing | $1.26B | -$45.5M | -$19.7M | -$465.1M | $148.7M | $332.4M |
| Free Cash Flow | -$630.2M | -$582.5M | -$566.8M | -$285.4M | -$176.6M | -$69.1M |
Figures from Canopy Growth's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Canopy Growth financials page for every line item.
Canopy Growth Company Profile
| Ticker | CGC |
|---|---|
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Headquarters | Smith Falls, Ontario, Canada |
| Fiscal Year End | March 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001737927 |
Frequently Asked Questions
What was Canopy Growth's revenue in fiscal 2026?
Canopy Growth (CGC) reported revenue of $346.8M for fiscal 2026.
What is Canopy Growth's annual revenue history?
Canopy Growth's annual revenue by fiscal year: 2021: $607.2M; 2022: $582.2M; 2023: $450.9M; 2024: $343.9M; 2025: $314.0M; 2026: $346.8M.
What was Canopy Growth's net income in fiscal 2026?
Canopy Growth reported net income of -$262.9M for fiscal 2026.
What was Canopy Growth's earnings per share (EPS) in fiscal 2026?
Canopy Growth's diluted EPS was -$0.88 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Canopy Growth generate in fiscal 2026?
Canopy Growth generated -$69.1M of free cash flow in fiscal 2026.
What was Canopy Growth's revenue last quarter?
In its most recent reported quarter (2027 Q1), Canopy Growth reported revenue of $100.4M.
How much debt does Canopy Growth have?
Canopy Growth reported $233.4M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Canopy Growth are outstanding?
Canopy Growth reported a weighted average of 422.3 million basic shares outstanding in 2027 Q1.
What is Canopy Growth's market cap?
Based on its latest closing price, Canopy Growth (CGC) has a market capitalization of about $322.2M.
When does Canopy Growth's fiscal year end?
Canopy Growth's fiscal year end, as registered with the SEC, is March 31.
Where is Canopy Growth headquartered?
Canopy Growth lists its business address in Smith Falls, Ontario, Canada in its SEC filings.
Canopy Growth Competitors & Similar Companies
See all 11 Medicinal Chemicals & Botanical Products companies →